34 related articles for article (PubMed ID: 10621853)
1. Isotretinoin for the treatment of nonobstructive azoospermia: a pilot study.
Amory JK; Muller CH; Walsh TJ
Asian J Androl; 2021; 23(5):537-540. PubMed ID: 33762477
[No Abstract] [Full Text] [Related]
2. Chemoprevention of oral cancer in animal models, and effect on leukoplakias in human patients with ZengShengPing, a mixture of medicinal herbs.
Sun Z; Guan X; Li N; Liu X; Chen X
Oral Oncol; 2010 Feb; 46(2):105-10. PubMed ID: 20022553
[TBL] [Abstract][Full Text] [Related]
3. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.
Tsao AS; Liu D; Martin J; Tang XM; Lee JJ; El-Naggar AK; Wistuba I; Culotta KS; Mao L; Gillenwater A; Sagesaka YM; Hong WK; Papadimitrakopoulou V
Cancer Prev Res (Phila); 2009 Nov; 2(11):931-41. PubMed ID: 19892663
[TBL] [Abstract][Full Text] [Related]
4. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO
Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.
Mulshine JL; Atkinson JC; Greer RO; Papadimitrakopoulou VA; Van Waes C; Rudy S; Martin JW; Steinberg SM; Liewehr DJ; Avis I; Linnoila RI; Hewitt S; Lippman SM; Frye R; Cavanaugh PF
Clin Cancer Res; 2004 Mar; 10(5):1565-73. PubMed ID: 15014005
[TBL] [Abstract][Full Text] [Related]
6. Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial.
Epstein JB; Wong FL; Millner A; Le ND
Head Neck; 1994; 16(6):539-44. PubMed ID: 7529754
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders.
Viglianisi G; Polizzi A; Grippaudo C; Cocuzza S; Leonardi R; Isola G
Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247942
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention in oral leukoplakia: challenges and current landscape.
Palma VM; Koerich Laureano N; Frank LA; Rados PV; Visioli F
Front Oral Health; 2023; 4():1191347. PubMed ID: 37293562
[TBL] [Abstract][Full Text] [Related]
9. Should local drug delivery systems be used in dentistry?
Costa JV; Portugal J; Neves CB; Bettencourt AF
Drug Deliv Transl Res; 2022 Jun; 12(6):1395-1407. PubMed ID: 34545538
[TBL] [Abstract][Full Text] [Related]
10. Early-Phase Interventional Trials in Oral Cancer Prevention.
McCarthy C; Fedele S; Ottensmeier C; Shaw RJ
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359746
[TBL] [Abstract][Full Text] [Related]
11. EVALUATION OF INNOVATIVE DIGITALLY CONTROLLED ER:YAG LASER IN SURGICAL TREATMENT OF ORAL LEUKOPLAKIA - A PRELIMINARY STUDY.
Gabrić D; Brailo V; Ivek A; Krpan K; Matulić N; Vrdoljak DV; Baraba A; Vučićević Boras V
Acta Clin Croat; 2019 Dec; 58(4):615-620. PubMed ID: 32595245
[TBL] [Abstract][Full Text] [Related]
12. Estimation of oral leukoplakia treatment records in the research of the Department of Maxillofacial and Oral Surgery, Medical University of Gdansk.
Starzyńska A; Pawłowska A; Renkielska D; Michajłowski I; Sobjanek M; Błażewicz I; Włodarkiewicz A
Postepy Dermatol Alergol; 2015 Apr; 32(2):114-22. PubMed ID: 26015781
[TBL] [Abstract][Full Text] [Related]
13. Interplay between EGR1 and SP1 is critical for 13-cis retinoic acid-mediated transcriptional repression of angiotensin type 1A receptor.
Snyder R; Thekkumkara T
J Mol Endocrinol; 2013 Jun; 50(3):361-74. PubMed ID: 23475749
[TBL] [Abstract][Full Text] [Related]
14. Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials.
Holpuch AS; Desai KG; Schwendeman SP; Mallery SR
J Carcinog; 2011; 10():23. PubMed ID: 22013393
[TBL] [Abstract][Full Text] [Related]
15. Use of oral isotretinoin in the management of rosacea.
Park H; Del Rosso JQ
J Clin Aesthet Dermatol; 2011 Sep; 4(9):54-61. PubMed ID: 21938271
[TBL] [Abstract][Full Text] [Related]
16. A review of the nonsurgical treatment of oral leukoplakia.
Ribeiro AS; Salles PR; da Silva TA; Mesquita RA
Int J Dent; 2010; 2010():186018. PubMed ID: 20339486
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study.
Piattelli A; Fioroni M; Santinelli A; Rubini C
Oral Oncol; 1999 May; 35(3):314-20. PubMed ID: 10621853
[TBL] [Abstract][Full Text] [Related]
18. The role of apoptosis and bcl-2 protein in topical treatment of oral leukoplakia with isotretinoin.
Tetè S; Pappalardo S; Rubini C; Salini L; Falco A; Perfetti EG
Minerva Stomatol; 1999 Sep; 48(9):411-8. PubMed ID: 10638174
[TBL] [Abstract][Full Text] [Related]
19. Oral lichen planus treated with 13-cis-retinoic acid (isotretinoin): effects on the apoptotic process.
Piattelli A; Carinci F; Iezzi G; Perrotti V; Goteri G; Fioroni M; Rubini C
Clin Oral Investig; 2007 Sep; 11(3):283-8. PubMed ID: 17483968
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
